AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2022

Nov 29, 2022

32845_dirs_2022-11-29_3bd734ab-3ee3-46a6-a8a2-e8855d0b0a7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2022-11-25

Reporting Person: SIDES TERI WOODWICK (SVP, Vascular Interventions)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-25	Common Stock	F	365	$36.02	Disposed	20616	Direct

Footnotes

F1: Includes 294 shares acquired through Employee Stock Purchase Plan for the phase ending 2/28/22 and 193 shares acquired for the phase ending 8/31/22.